Related Experiment Video
Updated: May 10, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Growth in children on renal replacement therapy: a shrinking problem?
Pediatric Nephrology (Berlin, Germany)
|June 25, 2013
Summary
Growth failure in children with chronic kidney disease (CKD) is decreasing due to improved care. Advances in managing end-stage renal disease (ESRD) have led to better growth and maturation outcomes globally.
Area of Science:
- Pediatric Nephrology
- End-Stage Renal Disease (ESRD) Research
- Growth and Development Studies
Background:
- Historically, growth failure was a significant complication of chronic kidney disease (CKD) and end-stage renal disease (ESRD).
- This failure contributed to increased morbidity and mortality in affected children.
- Multifactorial causes included poor nutrition, comorbidities (anemia, bone/mineral disorders), hormonal imbalances, and treatments like steroids.
Discussion:
- Franke et al. present findings on improved growth and maturation in pediatric ESRD patients, particularly in Germany.
- Advances in CKD and ESRD care over recent decades show a decreasing prevalence of growth failure.
- This aligns with reports of reduced childhood ESRD mortality in the USRDS, indicating better overall care.
Key Insights:
- The prevalence of growth failure in pediatric CKD and ESRD is declining.
- Improvements in medical management and treatment protocols are positively impacting child development.
- Enhanced care strategies are leading to better health outcomes for children with kidney disease.
Outlook:
- Continued advancements in pediatric nephrology are expected to further improve growth outcomes.
- Global implementation of best practices may lead to worldwide reductions in growth failure associated with kidney disease.
- Further research into optimizing nutritional and hormonal therapies is warranted.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...